Jul 27 2010 | Blogs
With its Critical Path Initiative over the past several years, the FDA has attempted to accelerate the drug development process by making it less empirical and more science-based.
|
Mar 10 2010 | White Papers
This report shows how untreated quality issues at even a single investigator site can negatively impact the results of an entire study. It identifies the elements that every trial should deem mandatory in order to avoid unnecessary failure.
|
Jan 28 2010 | News
Novella Clinical Inc. and OSI Pharmaceuticals, Inc. have announced that the companies will expand their existing clinical service agreement. Under the terms of the new agreement, effective February 1, 2010, Novella will provide clinical research and related services to OSI for a period of two years
|
Oct 14 2009 | Articles
With so many moving parts, the ability to repeatedly execute clinical trials with a high level of quality requires a comprehensive and adaptable Clinical Quality Management (CQM) program. The starting point of any CQM program consists of well-defined and documented Standard Operating Procedures (SOPs) for every aspect of running a clinical trial, including the peripheral departments and outsourced services/providers that play a vital role in your ability to execute clinical studies.
|
Nov 18 2008 | Articles
The healthcare industry is in a state of evolution. As a result, the efficiency of clinical trials materials (CTM) management services have come under increased scrutiny
|
May 19 2008 | Articles
With a growing number of clinical trials underway worldwide and an
increasing demand for comparator products used for these trials, the
pressure is on to not only find the drug of choice, but to find it at
the right time, in the right amounts and from a single batch, often in
multiple foreign territories.
|